United Therapeutics (UTHR) Retained Earnings (2009 - 2026)
United Therapeutics (UTHR) posted Retained Earnings of $8.8 billion for Q1 2026, up 981211.11% sequentially from $900000.0 in Q4 2025, and up 17.06% YoY from $7.5 billion in Q1 2025.
United Therapeutics (UTHR) Retained Earnings (2009 - 2026) Analysis & Trends
United Therapeutics has reported Retained Earnings for 18 years, with the latest figure at $8.8 billion in Q1 2026.
- Quarterly Retained Earnings rose 17.06% year-over-year to $8.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 billion (up 17.06% YoY) and the FY2025 annual result came in at $900000.0, down 99.99% from the prior year.
- Retained Earnings grew to $8.8 billion in Q1 2026 per UTHR's latest filing, from $900000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $8.8 billion in Q1 2026 and troughed at -$84.1 million in Q3 2022.
- A 5-year average of $4.5 billion and a median of $5.5 billion in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings plunged 318.41% in 2022, then soared 56523.44% in 2024.
- Over 5 years, Retained Earnings stood at $5.0 billion in 2022, then tumbled by 100.25% to -$12.8 million in 2023, then jumped by 56523.44% to $7.2 billion in 2024, then slumped by 99.99% to $900000.0 in 2025, then surged by 981211.11% to $8.8 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $8.8 billion, $900000.0, and $100000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -800.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.16 Bn |
| Mar 31, 2026 | 8.83 Bn |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 7.85 Bn |
| Mar 31, 2025 | 7.54 Bn |
| Dec 31, 2024 | 7.22 Bn |
| Sep 30, 2024 | 6.92 Bn |
| Jun 30, 2024 | 6.61 Bn |
| Mar 31, 2024 | 6.33 Bn |
| Dec 31, 2023 | -12.80 Mn |
| Sep 30, 2023 | 5.81 Bn |
| Jun 30, 2023 | 5.54 Bn |
| Mar 31, 2023 | -38.80 Mn |
| Dec 31, 2022 | 5.04 Bn |
| Sep 30, 2022 | -84.10 Mn |
| Jun 30, 2022 | 4.67 Bn |
| Mar 31, 2022 | 4.55 Bn |
| Dec 31, 2021 | -23.00 Mn |
| Sep 30, 2021 | -20.10 Mn |